Article Text

Download PDFPDF
Right pelvic mass in a patient with a radically resected carcinoid of the appendix
  1. N Fazio1,
  2. F Luca2,
  3. L Monfardini3,
  4. G Pelosi4,
  5. L Bodei5,
  6. K Lorizzo1,
  7. G Di Meglio1,
  8. B Gibelli6,
  9. D Ravizza7,
  10. G Bonomo3,
  11. C M Grana5,
  12. S Baio5,
  13. M Squadroni1,
  14. G Paganelli5,
  15. F de Braud1
  1. 1
    Medical Oncology, European Institute of Oncology, Milan, Italy
  2. 2
    Abdominopelvic Surgery, European Institute of Oncology, Milan, Italy
  3. 3
    Radiology, European Institute of Oncology, Milan, Italy
  4. 4
    Pathology, European Institute of Oncology, Milan, Italy
  5. 5
    Nuclear Medicine, European Institute of Oncology, Milan, Italy
  6. 6
    Endocrinology, European Institute of Oncology, Milan, Italy
  7. 7
    Endoscopy, European Institute of Oncology, Milan, Italy
  1. Correspondence to Dr N Fazio, Medical Oncology, European Institute of Oncology, 20141 Milan, Italy; nicola.fazio{at}ieo.it

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Clinical presentation

A 22-year-old male patient with a radiologically detected right pelvic mass presented without any symptoms. Two years before he underwent appendectomy due to acute appendicitis elsewhere, and a carcinoid was incidentally diagnosed. Our revised histological report confirmed a conventional carcinoid of the appendix, excluding a goblet cell carcinoid (adenocarcinoid). The tumour infiltrated the whole wall thickness without serosal invasion; margins were negative; the macroscopic size of the tumour had been omitted in the original pathology report.

Immunohistochemical chromogranin-A, neuron specific enolase, and synaptophysin were positive. Follow-up was negative over the two subsequent …

View Full Text

Footnotes

  • Robin Spiller, editor

  • NF, FL, LM, GP, LB, KL, GdiM, BG, DR, GB, CMG, SB and MS are members of the IEO NET Study Group, European Institute of Oncology, Milan, Italy.